跳至主要内容
临床试验/ITMCTR2100004634
ITMCTR2100004634招募中4 期

A study on the efficacy and safety of Shexiang Baoxin Pill in patients with chest pain due to non obstructive coronary artery disease

Shanghai Changzheng Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Aged 18~75 years, gender is not limited.
  • 2. Clinical diagnosis of angina pectoris or angina pectoris equivalent symptoms (attack at least twice a week), and coronary CTA or coronary angiography imaging examination of normal coronary artery or major vascular branches of the largest lesion < 50%;
  • 3. Willing to follow up and sign informed consent.

排除标准

  • 1. There was no angina pectoris without medication;
  • 2. Coronary CTA or coronary angiography examination showed that the largest lesion of major vascular branches was more than or equal to 50%;
  • 3. Severe cardiopulmonary vascular diseases: intractable heart failure or cardiogenic shock, hypertrophic obstructive cardiomyopathy, severe aortic stenosis, insufficiency, aortic dissection, pulmonary embolism;
  • 4. Patients with acute myocardial infarction within 3 months;
  • 5. Severe respiratory diseases, COPD or active pulmonary infection;
  • 6. The patients with poor blood pressure control received hypertension treatment, but before the end of the screening period, the hypertension was not controlled and / or the systolic blood pressure was >= 180mmhg and / or the diastolic blood pressure was >= 110mmhg;
  • 7. Severe liver and kidney diseases, such as liver and kidney dysfunction (alt, AST >= 1.5 times of the upper limit of normal value, Cr > 1.5 times of normal value), active liver disease, liver cirrhosis or uremia;
  • 8. Any other serious disease or condition, such as malignant tumor, severe anemia, severe renal artery stenosis, severe anxiety and depression (HAMD-17) and even suicide or manic mental illness;
  • Participated in other clinical studies within 30 days before enrollment;
  • 10. Pregnant and lactating women and women and men with recent family planning;
  • 11. Allergic constitution or allergy to known components of the study drug;
  • 12. Patients judged by the researcher as unsuitable for the study.

研究者

相似试验